| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2023 |
4
| Makker Gotham (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 10,312 shares
@ $21.0318, valued at
$216.9k
Sold 4,677 shares
@ $21.1383, valued at
$98.9k
|
|
| 10/02/2023 |
8-K
| Quarterly results |
| 08/21/2023 |
4
| Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 1,534 shares
@ $15.471, valued at
$23.7k
|
|
| 08/21/2023 |
4
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 4,767 shares
@ $15.471, valued at
$73.8k
|
|
| 08/21/2023 |
4
| Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 284 shares
@ $15.471, valued at
$4.4k
|
|
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
4
| Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Exercised 725 restricted stock units
@ $0 |
|
| 08/15/2023 |
4
| Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Exercised 3,989 restricted stock units
@ $0 |
|
| 08/15/2023 |
4
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Exercised 7,979 restricted stock units
@ $0 |
|
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/19/2023 |
4
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 4,122 shares
@ $21.375, valued at
$88.1k
|
|
| 05/19/2023 |
4
| Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 1,330 shares
@ $21.375, valued at
$28.4k
|
|
| 05/19/2023 |
4
| Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 245 shares
@ $21.375, valued at
$5.2k
|
|
| 05/16/2023 |
4
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Exercised 7,979 restricted stock units
@ $0 |
|
| 05/16/2023 |
4
| Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Exercised 725 restricted stock units
@ $0 |
|
| 05/16/2023 |
4
| Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Exercised 3,989 restricted stock units
@ $0 |
|
| 05/09/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/05/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/01/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/05/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/05/2023 |
SC 13D/A
| RTW INVESTMENTS, LP reports a 23% stake in Rocket Pharmaceuticals, Inc. |
| 04/05/2023 |
4
| RTW INVESTMENTS, LP (10% Owner) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Acquired 529,038 shares
@ $0
Acquired 1 options to buy
@ $40.0324, valued at
$40
Acquired 61,705 warrants
@ $65.23, valued at
$4M
|
|
|